Nigeria to export cashew nuts by 2019
The Minister of Agriculture and Rural Development, Mr Audu
Ogbeh, on Tuesday, said that the country would start processing its raw
cashew nuts for export by 2019.
Ogbeh made this known at the maiden edition of the 2017 First Bank Agric Expo in Lagos.
The expo is tagged: Reinventing Agriculture for Sustainable National Development.
“So in the next two years we will no longer export raw cashew nuts, but roast the cashew nuts for export.
“If we produce a tonne of roasted cashew it will be sold at the international price of $10,000, whereas a tonne of raw cashew nuts sells for $1,200.”
Ogbeh also said that Nigeria shipped a total of $600,000 worth of raw cashew nuts to Vietnam alone in 2016.
(NAN)
Ogbeh made this known at the maiden edition of the 2017 First Bank Agric Expo in Lagos.
The expo is tagged: Reinventing Agriculture for Sustainable National Development.
According to him, the current worth of a tonne of roasted or
processed cashew nut for export is $10,000 while the raw cashew nut is
sold for $1,200.
He said it would be better to process the nuts for export
instead of exporting raw cashew nuts in order to benefit from the high
cost of cashew nuts.“So in the next two years we will no longer export raw cashew nuts, but roast the cashew nuts for export.
“If we produce a tonne of roasted cashew it will be sold at the international price of $10,000, whereas a tonne of raw cashew nuts sells for $1,200.”
Ogbeh also said that Nigeria shipped a total of $600,000 worth of raw cashew nuts to Vietnam alone in 2016.
(NAN)
ABEOKUTA-The President
of Pentecostal Sanctuary Bible Ministries Worldwide, Prophet Sunday
Iyunade has predicted a possible end to the reign of democracy in
Nigeria after the administration of Muha
Read more at: http://www.vanguardngr.com/2017/03/buharis-tenure-may-end-democracy-nigeria-clergy/
Read more at: http://www.vanguardngr.com/2017/03/buharis-tenure-may-end-democracy-nigeria-clergy/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
“The BRCA1 and BRCA2 genes are guardians that look after DNA in our
body.
“These are really critical genes in every cell of our body and they go
through and repair DNA when it gets damaged,’’ Simpson said.
He noted that by using a computer programme to map the Genome sequencing
of mutations in 560 breast cancers, were able to look at different
patterns of mutation and understand how a tumour had arisen.
“Results showed that almost 22 per cent of breast tumours had a genetic
signature reflecting a BRCA deficiency, even though the patient had not
always inherited a mutation in one of the two genes,’’ Simpson said.
According to the researcher, in clinical trials at the moment, PARP
inhibitor drugs can act to restore these BRCA1 or BRCA2 genes.
“It’s very significant; it’s building a really big body of evidence to
suggest that in the future we can sequence a patient’s tumour.
“We can understand the mutation and say whether the patient will respond
better to chemotherapy of the PARP drug.
“In the future we can see this kind of test becoming a kind of
diagnostic that will determine what type of therapy a patient will have.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
“The BRCA1 and BRCA2 genes are guardians that look after DNA in our
body.
“These are really critical genes in every cell of our body and they go
through and repair DNA when it gets damaged,’’ Simpson said.
He noted that by using a computer programme to map the Genome sequencing
of mutations in 560 breast cancers, were able to look at different
patterns of mutation and understand how a tumour had arisen.
“Results showed that almost 22 per cent of breast tumours had a genetic
signature reflecting a BRCA deficiency, even though the patient had not
always inherited a mutation in one of the two genes,’’ Simpson said.
According to the researcher, in clinical trials at the moment, PARP
inhibitor drugs can act to restore these BRCA1 or BRCA2 genes.
“It’s very significant; it’s building a really big body of evidence to
suggest that in the future we can sequence a patient’s tumour.
“We can understand the mutation and say whether the patient will respond
better to chemotherapy of the PARP drug.
“In the future we can see this kind of test becoming a kind of
diagnostic that will determine what type of therapy a patient will have.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
“The BRCA1 and BRCA2 genes are guardians that look after DNA in our
body.
“These are really critical genes in every cell of our body and they go
through and repair DNA when it gets damaged,’’ Simpson said.
He noted that by using a computer programme to map the Genome sequencing
of mutations in 560 breast cancers, were able to look at different
patterns of mutation and understand how a tumour had arisen.
“Results showed that almost 22 per cent of breast tumours had a genetic
signature reflecting a BRCA deficiency, even though the patient had not
always inherited a mutation in one of the two genes,’’ Simpson said.
According to the researcher, in clinical trials at the moment, PARP
inhibitor drugs can act to restore these BRCA1 or BRCA2 genes.
“It’s very significant; it’s building a really big body of evidence to
suggest that in the future we can sequence a patient’s tumour.
“We can understand the mutation and say whether the patient will respond
better to chemotherapy of the PARP drug.
“In the future we can see this kind of test becoming a kind of
diagnostic that will determine what type of therapy a patient will have.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Sydney – New research
finds more patients suffering from breast cancer could be treated with a
drug previously thought to only help those with a genetic gene
deficiency.
Study researcher Dr. Peter Simpson told Xinhua that when there’s a
mutation or deficiency in specific genes, a person can become more
susceptible to develop breast cancer.
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Read more at: http://www.vanguardngr.com/2017/03/research-uncovers-breakthrough-breast-cancer-drug/
Comments
Post a Comment